<DOC>
	<DOCNO>NCT01750307</DOCNO>
	<brief_summary>Brief summary The aim study provide preliminary data relationship Essential Fatty Acids ( EFAs ) cognitive electrophysiological measure brain behavioural function adult attention deficit hyperactivity disorder ( ADHD ) control . This main aim achieve two way . First investigator measure relationship various measure blood level EFAs ADHD case control . Secondly , potential effect dietary supplementation EFAs cognitive-electrophysiological behavioural measure ADHD case investigate . We evaluate extent change neuronal activity cognitive performance relate behavioural functional measure time . This carry conduct randomise controlled trial fish oil supplementation adult ADHD ( The OCEAN study : Oils Cognitive Effects Adult Neurodevelopment ) . The study design 6-month double blind placebo control study group 80 adult diagnosis ADHD . The group divide 40 participant receive EFA dietary supplement 40 receive placebo , 6-month period . Allocation EFA dietary supplementation placebo group randomly allocate blind investigator participant . In addition sample 30 control take part baseline level assessment use case-control comparison investigate link EFA blood level cognitive-electrophysiological function one time point . The study design enable preliminary data address follow hypothesis : 1 . Changes cognitive electrophysiological function ( neuronal activity ) find follow supplementation dietary EFAs . 2 . Changes cognition and/or brain activity relate blood level EFAs . 3 . Changes cognitive performance electrophysiological parameter correlate behavioural function , affective regulation functional impairment . 4 . At baseline , case-control difference EFA blood-levels find link cognitive electrophysiological function .</brief_summary>
	<brief_title>The Relationship Essential Fatty Acids Adult ADHD : The OCEAN Study ( Oils Cognitive Effects Adult ADHD Neurodevelopment )</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Cases : Clinical diagnosis ADHD ( combine inattentive type ) Controls : Screen threshold ADHD Cases : Autism spectrum disorder Recurrent major depression Bipolar I disorder Psychotic disorder Obsessive compulsive disorder Learning difficulty ( IQ &lt; 80 ) Neurological problem Drug abuse Those already take EFA supplement Metabolic condition Infectious diseases Controls : ADHD All exclusion criterion case</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder ( ADHD )</keyword>
	<keyword>Essential fatty acid ( EFAs )</keyword>
	<keyword>Electroencephalography ( EEG )</keyword>
	<keyword>Event-related potential ( ERP )</keyword>
	<keyword>Omega 3</keyword>
	<keyword>Randomised Control Trial</keyword>
	<keyword>Fish oil</keyword>
	<keyword>Supplementation</keyword>
	<keyword>Reading</keyword>
	<keyword>Spelling</keyword>
	<keyword>Behaviour</keyword>
	<keyword>Emotional lability</keyword>
</DOC>